BERSANI, Samantha
 Distribuzione geografica
Continente #
NA - Nord America 2.980
EU - Europa 2.896
AS - Asia 1.743
SA - Sud America 243
Continente sconosciuto - Info sul continente non disponibili 69
AF - Africa 53
OC - Oceania 5
Totale 7.989
Nazione #
US - Stati Uniti d'America 2.876
RU - Federazione Russa 991
SG - Singapore 650
GB - Regno Unito 563
IT - Italia 532
CN - Cina 471
BR - Brasile 191
DE - Germania 158
HK - Hong Kong 158
VN - Vietnam 147
SE - Svezia 124
BD - Bangladesh 116
FI - Finlandia 104
FR - Francia 103
IE - Irlanda 91
NL - Olanda 72
CA - Canada 58
KR - Corea 45
IN - India 33
AT - Austria 28
ES - Italia 28
UA - Ucraina 26
JP - Giappone 24
MX - Messico 24
IQ - Iraq 19
AR - Argentina 17
PL - Polonia 15
TR - Turchia 15
BE - Belgio 14
NG - Nigeria 14
ID - Indonesia 13
TG - Togo 12
VE - Venezuela 9
CO - Colombia 8
CZ - Repubblica Ceca 8
UZ - Uzbekistan 8
CH - Svizzera 7
CL - Cile 7
MA - Marocco 7
BJ - Benin 6
JO - Giordania 6
SA - Arabia Saudita 6
AU - Australia 5
CR - Costa Rica 5
LT - Lituania 5
ZA - Sudafrica 5
IR - Iran 4
JM - Giamaica 4
PY - Paraguay 4
AL - Albania 3
EC - Ecuador 3
HR - Croazia 3
KG - Kirghizistan 3
MY - Malesia 3
PH - Filippine 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
BG - Bulgaria 2
DZ - Algeria 2
GE - Georgia 2
GR - Grecia 2
HN - Honduras 2
KE - Kenya 2
KZ - Kazakistan 2
NI - Nicaragua 2
PK - Pakistan 2
SI - Slovenia 2
TH - Thailandia 2
TN - Tunisia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CM - Camerun 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GT - Guatemala 1
HT - Haiti 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MT - Malta 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
QA - Qatar 1
SN - Senegal 1
Totale 7.918
Città #
Southend 462
Dallas 384
Singapore 363
Moscow 350
Ashburn 346
San Jose 282
Chandler 211
Hong Kong 155
Jacksonville 144
Verona 137
Ann Arbor 130
Council Bluffs 130
Woodbridge 102
Beijing 101
Dublin 85
New York 75
The Dalles 68
Houston 59
Los Angeles 56
Munich 56
Hanoi 43
Ho Chi Minh City 40
Helsinki 39
Santa Clara 31
Shenyang 29
Buffalo 27
Lawrence 27
Princeton 27
Rome 27
Nanjing 25
Madrid 24
Changsha 22
Wilmington 22
Tokyo 20
Denver 19
Hebei 19
London 19
Jinan 18
Orem 18
Brescia 17
Tianjin 17
Guangzhou 16
Milan 16
São Paulo 16
Frankfurt am Main 15
Vienna 15
Abuja 14
Brussels 14
Warsaw 14
Montreal 13
Ningbo 13
Redondo Beach 13
Turku 13
Boardman 12
Lomé 12
Mexico City 12
Stockholm 12
Toronto 12
Amsterdam 11
Chicago 11
Bologna 10
Brooklyn 10
Columbus 10
Nuremberg 10
Phoenix 10
Sindelfingen 10
Seattle 9
Atlanta 8
Chennai 8
Dearborn 8
Fuzhou 8
Haikou 8
Lappeenranta 8
Paris 8
Poplar 8
Shanghai 8
Zhengzhou 8
Manchester 7
Newark 7
San Francisco 7
Ankara 6
Baghdad 6
Barnet 6
Cotonou 6
Curitiba 6
Piscataway 6
Redmond 6
Seoul 6
Taizhou 6
Tashkent 6
Augusta 5
Belo Horizonte 5
Boston 5
Brno 5
Charlotte 5
Falkenstein 5
Kyiv 5
Nanchang 5
Naples 5
Norwalk 5
Totale 4.760
Nome #
Instabilità dei microsatelliti nei carcinomi duttali e nei tumori endocrini del pancreas 388
A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status 297
Whole-genome landscape of pancreatic neuroendocrine tumours 294
Expression of the antiapoptotic protein BAG3 is a feature of pancreatic adenocarcinoma and its overexpression is associated with poorer survival 264
Anti-viral state segregates two molecular phenotypes of pancreatic adenocarcinoma: Potential relevance for adenoviral gene terapy 237
A cross-species analysis in pancreatic neuroendocrine tumors reveals molecular subtypes with distinctive clinical, metastatic, developmental, and metabolic characteristics 234
Anti-viral state segregates two molecular phenotypes of pancreatic adenocarcinoma: Potential relevance for adenoviral gene therapy 229
Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models 224
Long-Term Survivor of Intrahepatic Cholangiocarcinoma for over 18 Years: Case Study with Longitudinal Histo-molecular and Tumor Immune Microenvironment Characterization and Systematic Review of the Literature 220
MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases 219
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 215
Chromosome 3p alterations in pancreatic endocrine neoplasia 211
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing 205
A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns 203
Molecular characterization of Pancreatic NeuroEndocrine Tumors (PanNETs) 203
Reporting tumor molecular heterogeneity in histopathological diagnosis 203
Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice? 202
Divergent mutational processes distinguish hypoxic and normoxic tumours 196
Author Correction: The landscape of viral associations in human cancers 195
Mixed adenoneuroendocrine carcinomas of the gastrointestinal tract: targeted next-generation sequencing suggests a monoclonal origin of the two components 190
Diagnostic usefulness of fluorescent cytogenetics in differentiating chromophobe renal cell carcinoma from renal oncocytoma: a validation study combining metaphase and interphase analyses 188
Genotypic Intratumoral Heterogeneity in Breast Carcinoma with HER2/neu Amplification Evaluation According to ASCO/CAP Criteria 188
The analysis of PIK3CA mutations in gastric carcinoma and metanalysis of literature suggest that exon-selectivity is a signature of cancer type 188
Classical lobular breast carcinoma consistently lacks topoisomerase-IIα gene amplification: implications for the tailored use of anthracycline-based chemotherapies 187
Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours 175
HER-2/neu assessment in breast cancer using the original FDA and new ASCO/CAP guideline recommendations: impact on selecting patients for herceptin therapy 169
Suitability of infiltrative lobular breast carcinoma for anti-human epidermal growth factor receptor 2 treatment after the ASCO/CAP and 2009 St Gallen International Expert Consensus meeting 164
MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior 160
Molecular characterization of extrahepatic cholangiocarcinoma: perihilar and distal tumours display divergent genomic and transcriptomic profiles 153
Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer 151
Author Correction: Pan-cancer analysis of whole genomes 151
Combined burden and functional impact tests for cancer driver discovery using DriverPower 146
Irrelevance of Microsatellite Instability in the Epidemiology of Sporadic Pancreatic Ductal Adenocarcinoma 144
Comprehensive molecular characterization of mitochondrial genomes in human cancers 142
Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples 139
Integrative pathway enrichment analysis of multivariate omics data 137
Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing 128
The landscape of viral associations in human cancers 127
FISH Scoring on Paraffin Sections Versus Single-cell Suspension for Chromophobe Renal Carcinoma and Renal Oncocytoma 112
Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size 111
Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig 95
Genomic footprints of activated telomere maintenance mechanisms in cancer 94
Inferring structural variant cancer cell fraction 73
High fidelity of Claudin-18.2 expression in primary and matched metastatic (lymph nodes, peritoneum, and liver) pancreatic ductal adenocarcinoma: a foundation for targeted therapy 38
Totale 7.989
Categoria #
all - tutte 24.681
article - articoli 22.755
book - libri 0
conference - conferenze 1.441
curatela - curatele 0
other - altro 485
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.362


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022137 0 0 0 34 8 4 4 16 6 5 21 39
2022/2023542 43 77 44 87 56 133 3 29 56 0 9 5
2023/2024381 12 15 29 40 22 61 4 51 27 33 64 23
2024/20251.187 59 53 76 156 57 58 91 67 144 78 144 204
2025/20263.660 240 166 348 559 863 221 298 170 316 215 104 160
2026/2027409 44 79 137 149 0 0 0 0 0 0 0 0
Totale 7.989